Lercanidipine: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 26: | Line 26: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Line 37: | Line 32: | ||
It is sold under various commercial names including '''Zanidip'''. | It is sold under various commercial names including '''Zanidip'''. | ||
==Further | ==Further Reading== | ||
<div class="references-small"> | <div class="references-small"> | ||
<references/> | <references/> | ||
Line 45: | Line 40: | ||
</div> | </div> | ||
==External | ==External Links== | ||
* {{DiseasesDB|31597}} | * {{DiseasesDB|31597}} | ||
[[Category: Calcium channel blockers]] | [[Category: Calcium channel blockers]] | ||
[[Category: Cardiovascular Drugs]] | |||
[[Category:Drug]] | |||
[[Category: | |||
Revision as of 20:25, 23 July 2014
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C36H41N3O6 |
Molar mass | 611.727 g/mol |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Lercanidipine is a calcium channel blocker of the dihydropyridine class.
It is sold under various commercial names including Zanidip.
Further Reading
- Lin T, Voon W, Yen H, Huang C, Su H, Lai W, Sheu S (2006). "Lercanidipine and losartan effects on blood pressure and fibrinolytic parameters". Kaohsiung J Med Sci. 22 (4): 177–83. PMID 16679299.
- Martinez M, Lopes L, Coelho E, Nobre F, Rocha J, Gerlach R, Tanus-Santos J (2006). "Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension". J Cardiovasc Pharmacol. 47 (1): 117–22. PMID 16424795.
- Agrawal R, Marx A, Haller H (2006). "Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension". J Hypertens. 24 (1): 185–92. PMID 16331117.
External Links
Categories:
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- CS1 maint: Multiple names: authors list
- Calcium channel blockers
- Cardiovascular Drugs
- Drug